Overview
OPCH market data
Price History
OPCH price chart
Valuation & Profitability
- P/E (TTM)
- 17.24 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $1.27 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.57 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 3.7% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $18.01 – $36.80 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $3.6B · P/B 3.81 · P/S 0.63.
Company News
Deutsche Bank Downgrades Option Care Health to Hold, Lowers Price Target to $24Benzinga · Jul 30, 2026, 9:41 AM
Option Care Health shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 adjusted EPS guidance above estimates.Benzinga · Jul 29, 2026, 12:07 PM
Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026Globenewswire Inc · Jul 29, 2026, 11:15 AM
Option Care Health Q2 Adj. EPS $0.45 Beats $0.43 Estimate, Sales $1.442B Beat $1.419B EstimateBenzinga · Jul 29, 2026, 11:03 AM
Option Care Health Raises FY2026 Adj EPS Guidance from $1.82-$1.92 to $1.85-$1.92 vs $1.84 Est; Affirms FY2026 Sales Guidance of $5.675B-$5.775B vs $5.711B EstBenzinga · Jul 29, 2026, 10:56 AM
8-K filing — Option Care Health, Inc. (OPCH)SEC EDGAR · Jul 29, 2026, 10:56 AM
Stephens & Co. Downgrades Option Care Health to Equal-Weight, Lowers Price Target to $24Benzinga · Jul 17, 2026, 3:06 PM
Goldman Sachs Initiates Coverage On Option Care Health with Neutral Rating, Announces Price Target of $22Benzinga · Jun 8, 2026, 5:20 PM
Option Care Health Appoints Robert Okunski as Vice President, Investor RelationsGlobenewswire Inc · Jun 4, 2026, 11:15 AM
Alpha Buying: When CEOs and CFOs Buy TogetherBenzinga · May 28, 2026, 4:20 PM